Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2026-06-28 @ 2:03 PM
Study NCT ID:
NCT01858935
Status:
COMPLETED
Last Update Posted:
2017-05-11
First Post:
2013-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection in Normal Healthy Subjects
Sponsor:
Bristol-Myers Squibb
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy | View |
Keywords: